At 76 years old, Pedro Lopez loves to play golf and keep a full schedule as a husband of 53 years, a father and a grandfather ...

"This is a very promising tool. So I feel like it can be employed very well. That's why I am not in the bracket of people who are overly worried about it," he says.

One HHS research project cited by the Times ultimately seeks to use autonomous AI to help manage heart failure patients, ...

Artificial intelligence (AI) tools can help physicians predict treatment and survival outcomes in patients with advanced ...

Moderna built an artificial intelligence that reads a patient’s tumor and decides what that patient’s medicine should be.

Big manufacturers planning to produce more of the forever chemicals to meet demand from datacentres ...

From developing an AI health coach to developing a nanotech cancer vaccine, these SA researchers are taking centre stage on ...

Sure, Moderna is developing several mRNA-based cancer therapies, but no mRNA-based vaccine has ever been approved for cancer.

Moderna and Merck's Phase 3 melanoma vaccine trial showed positive results, but full data and FDA approval are still pending ...

WASHINGTON – Today, Congressman Michael McCaul (R-Texas) — founder and co-chair of the Congressional Childhood Cancer Caucus ...

Eric Lefkofsky, Tempus AI founder and CEO, joins 'The Exchange' to discuss AI's role in healthcare, advancing cancer research ...

Eric Lefkofsky, Tempus AI founder and CEO, joins 'The Exchange' to discuss AI's role in healthcare, advancing cancer research ...